Details

The impact of bone marrow involvement on prognosis in diffuse large B-cell lymphoma : an 18F-FDG PET/CT volumetric segmentation study
ID Doma, Andrej (Author), ID Studen, Andrej (Author), ID Jezeršek Novaković, Barbara (Author)

.pdfPDF - Presentation file, Download (3,38 MB)
MD5: C64A8852408F8D1F78D3DE8296E463D2
URLURL - Source URL, Visit https://www.mdpi.com/2072-6694/16/22/3762 This link opens in a new window

Abstract
Background: This study assessed the prognostic value of tumor burden in bone marrow (BM) and total disease (TD), as depicted on 18F-FDG PET/CT in 140 DLBCL patients, for complete remission after first-line systemic treatment (iCR) and 3- and 5-year overall survival (OS3 and OS5). Methods: Baseline 18F-FDG PET/CT scans of 140 DLBCL patients were segmented to quantify metabolic tumor volume (MTV), total lesion glycolysis (TLG), and SUVmax in BMI, findings elsewhere (XL), and TD. Results: Bone marrow involvement (BMI) presented in 35 (25%) patients. Median follow-up time was 47 months; 79 patients (56%) achieved iCR. iCR was significantly associated with TD MTV, XL MTV, BM PET positivity, and International Prognostic Index (IPI). OS3 was significantly worse with TD MTV, XL MTV, IPI, and age. OS5 was significantly associated with IPI, but not with MTVs and TLGs. Univariate factors predicting OS3 were XL MTV (hazard ratio [HR] = 1.29), BMI SUVmax (HR = 0.56), and IPI (HR = 1.92). By multivariate analysis, higher IPI (HR = 2.26) and BMI SUVmax (HR = 0.91) were significant independent predictors for OS3. BMI SUVmax resulted in a negative coefficient and hence indicated a protective effect. Conclusions: Baseline 18F-FDG PET/CT MTV is significantly associated with survival. BMI identified on 18F-FDG PET/CT allows appropriate treatment that may improve survival.

Language:English
Keywords:bone marrow, diffuse large B-cell lymphoma, survival, 18F-FDG, PET/CT, MTV
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
FMF - Faculty of Mathematics and Physics
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:17 str.
Numbering:Vol. 16, iss. 22, art. 3762
PID:20.500.12556/RUL-176040 This link opens in a new window
UDC:616.4
ISSN on article:2072-6694
DOI:10.3390/cancers16223762 This link opens in a new window
COBISS.SI-ID:214486531 This link opens in a new window
Publication date in RUL:19.11.2025
Views:341
Downloads:198
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Cancers
Shortened title:Cancers
Publisher:MDPI
ISSN:2072-6694
COBISS.SI-ID:517914137 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:kostni mozeg, difuzni velikocelični limfom B, preživetje

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0321
Name:Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri različnih vrstah raka

Funder:ARRS - Slovenian Research Agency
Project number:P1-0389
Name:Medicinska fizika

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back